CEO, Nucleai
Biography
CEO and co-founder of Nucleai – a computational pathology company making cancer diagnostics more accurate and effective using AI and Machine learning technologies. Nucleai is developing an AI platform which will improve workflow by automating repetitive and time-consuming tasks. The company products are focused on the clinical applications in pathology. Before establishing Nucleai Avi served more than 20 years in the Israeli intelligence forces in various R&D leadership roles. During his service, Avi Established and lead AI and Data science department specializing in computer vision. Avi holds an MSC. in Geoinformation (Cum laude) from the Technion.
AI & Data Sciences Showcases:
Nucleai
Our mission, expertise, and passion are to improve cancer diagnostics. We aim to make biopsy interpretations accurate, efficient, and accessible in order to improve the current standard of care in the field of oncology and to expedite the development of novel cancer treatments.
Session Abstract – PMWC 2020 Silicon Valley
Track 7 - January 22 9.00 A.M.-3.45 P.M.,Track 6 - January 23 11.15 A.M.-11.30 A.M.,Track 2 - January 24 11.15 A.M.-4.00 P.M.
The PMWC 2020 AI Company Showcase will provide a 15-minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.
